Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-15

Study Completion Date

2021-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety and protection of patients and health care providers (HCP). The aim of this study is to identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19 (COVID-19) with a worldwide survey of HCP.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease

NCT05598489

Inflammatory Bowel Diseases Ulcerative Colitis Crohn Disease +1 more

UNKNOWN

Vaccination Practices for Inflammatory Bowel Disease Patients in China With Gastroenterologists

NCT04948723

Inflammatory Bowel Diseases

COMPLETED

Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives

NCT01140802

Inflammatory Bowel Disease

TERMINATED

Inflammatory Bowel Disease (IBD) and Covid-19 Infection

NCT04492267

Inflammatory Bowel Disease

UNKNOWN

Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease

NCT03536091

Inflammatory Bowel Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The 20-item survey questionnaire was sent to physician members of the American Society for Gastrointestinal Endoscopy Special Interest Group in Interventional IBD, Chinese IBD Society Endoscopy Interest Group, and the China Crohn's and Colitis Foundation. The data of the survey was collected and analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

one group that is IBD endoscopist who perform the endoscopy for IBD patients

Complete the questionnaire online

observation

Intervention Type OTHER

IBD doctors who perform the endoscopy perform the questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observation

IBD doctors who perform the endoscopy perform the questionnaire

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

endoscopy with no drug

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Doctors who are involved in the endoscopic treatment of IBD patients;
2. The endoscopist reads and signs an informed consent online. -

Exclusion Criteria

1. Doctors who are not involved in the endoscopic treatment of IBD patients
2. Doctors who need the help of an agent, a witness, or someone else who can not complete the questionnaire independently.
3. Other conditions that the researchers considered unsuitable for inclusion or influenced the participants'ability to complete the study.-

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes